Top
Georganics

Home All Chemicals Phenylpyruvic acid

Phenylpyruvic acid

Product has been discontinued.

CAS#[156-06-9]
G-codeGEO-02572
EC number205-847-1
Molecular formulaC9H8O3
Molecular weight164.16
Synonyms 2-Oxo-3-phenylpropanoic acid ; 2-Oxo-3-phenylpropionic acid ; alpha-Keto-DL-phenylalanine ; 3-phenylpyruvic acid
Structure of Phenylpyruvic acid

For more information or to place an inquiry, please email us to
georganics@georganics.sk or use our contact form

Pack Sizes & Pricing

Georganics offers flexible supply options for customers requiring anything from gram-scale quantities for research and development through to multi-kilogram shipments for industrial applications. Prices are available upon request and are based on product specification, quantity, packaging requirements, and delivery destination.

Please get in touch and our team will provide a tailored quotation. Please email us to georganics@georganics.sk or use our contact form

Structural identification

CAS#[156-06-9]
G-codeGEO-02572
EC number205-847-1

Regulatory Information

Not regulated as a dangerous good.

GHS pictogram
GHS07_harmful
Signal WordWarning
Hazard Statements
H315 - H319 - H335

H315 – Causes skin irritation
H319 – Causes serious eye irritation
H335 – May cause respiratory irritation

Precautionary Statements
P261 - P280 - P302+352 - P305+351+338

P261 – Avoid breathing dust/fume/gas/mist/vapours/spray:
P280 – Wear protective gloves/protective clothing/eye protection/face protection:
P302+352 – IF ON SKIN: Wash with soap and water
P305+351+338 – IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing

Product categorization

Description

Show full description
Phenylpyruvic acid [156-06-9] or 2-oxo-3-phenylpropanoic acid is a keto acid that exists in equilibrium with its E- and Z-enol tautomers. It is a white to yellow crystalline solid with the melting point of 150-154 °C.[1] It is a product from the oxidative deamination of phenylalanine. When the activity of the enzyme phenylalanine hydroxylase is reduced, the amino acid phenylalanine accumulates and gets converted into phenylpyruvic acid (phenylpyruvate), which leads to Phenylketonuria.

Preparation of Phenylpyruvic acid:

It can pre prapared by hydrolysis of aminocinnamic acid derivatives e.g. α-acetaminocinnamic acid.[2] It has been prepared by condensation of benzaldehyde and glycine derivatives to give phenylazlactone, which is then hydrolyzed with acid- or base-catalysis.[3] It can also be synthesized by catalytic carbonylation of a benzyl halide in the presence of a catalytic system based on carbonyl complexes of cobalt or precursors.[4]

Application:

Phenylpyruvate derivatives can be potential inhibitors of the phenylpyruvate tautomerase activity catalysed by the Macrophage Migration Inhibitory Fator (MIF) which has been identified as a pro-inflammatory cytokine.[5] It was used in the synthesis of series of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives with anti-acetylcholinesterase activity.[6] Phenylpyruvate was used in the synthesis of quinoxaline derivatives targeting HIV reverse transcriptase enzyme.[7] Reductive amination of phenylpyruvic acid gives phenylalanine.[8]

Product categorization (Chemical groups):

Main category: Second level: Third level: _______________________________________________________________________
[1] S. Liu, R. Shang, L. Shi, D. C. Wan, H. Lin Eur. J. Med. Chem. 2014, 81, 237. doi:10.1016/j.ejmech.2014.05.020 [2] R. M. Herbst, D. Shemin Org. Synth. 1939, 19, 77. doi:10.15227/orgsyn.019.0077 [3] A. J. M. Carpy, P. P. Haasbroek, D. W. Oliver Med. Chem. Res. 2004, 13, 565. doi:10.1007/s00044-004-0102-y [4] M. Foa, A. Moro, A. Gardano, L. Cassar Process for preparing phenyl pyruvic acids 1982, Montedison S.p.A. US4481369A. [5] J. B. Lubetsky, M. Swope, C. Dealwis, P. Blake, E. Lolis Biochemistry 1999, 38 (22), 7346. doi:10.1021/bi990306m [6] S. J. Liu, L. Yang, X. G. Liu, Y. Luo, Z. J. Cao, D. C. C. Wan, H. Q. Lin, C. Hu Lett. Drug Des. Discov. 2010, 7 (1), 5. doi:10.2174/157018010789869343 [7] L. Fabian, M. T. Porro, N. Gómez, M. Salvatori, G. Turk, D. Estrin, A. Moglioni Eur. J. Med. Chem. 2020, 188, 111987. doi:10.1016/j.ejmech.2019.111987 [8] A. S. C. Chan, C. C. Chen, Y. C. Lin Appl. Catal. A: Gen 1994, 119 (1), L1. doi:10.1016/0926-860X(94)85018-6

Similar products